Electronic Resource
Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up
العنوان: | Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up |
---|---|
المؤلفون: | Pioltelli, M, Pungolino, E, D'Adda, M, Elena, C, Borin, L, Perego, A, Malato, S, Spina, F, Artale, S, Carraro, M, Orofino, N, Anghilieri, M, Farina, M, Latargia, M, Iurlo, A, Trojani, A, Turrini, M, Caramella, M, Spedini, P, Rossi, G, Morra, E, Cairoli, R, Pioltelli ML, Pungolino E, D'adda M, Elena C, Borin LM, Perego A, Malato S, Spina F, Artale S, Carraro M, Orofino N, Anghilieri M, Farina M, Latargia ML, Iurlo A, Trojani A, Turrini M, Caramella M, Spedini P, Rossi G, Morra E, Cairoli R |
بيانات النشر: | 2018 |
نوع الوثيقة: | Electronic Resource |
مصطلحات الفهرس: | Hematology, info:eu-repo/semantics/conferenceObject |
URL: | info:eu-repo/semantics/altIdentifier/wos/WOS:000454842806294 60th Annual Meeting of the American-Society-of-Hematology (ASH) - DEC 01-04, 2018 volume:132 issue:S1 journal:BLOOD |
الاتاحة: | Open access content. Open access content |
ملاحظة: | English |
Other Numbers: | ITBAO oai:boa.unimib.it:10281/409417 10.1182/blood-2018-99-113496 1376713946 |
المصدر المساهم: | BICOCCA OPEN ARCH From OAIster®, provided by the OCLC Cooperative. |
رقم الانضمام: | edsoai.on1376713946 |
قاعدة البيانات: | OAIster |
الوصف غير متاح. |